Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Jullien

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Biotechniques|October 13, 2011
LUEGO: a cost and time saving gel shift procedureNicolas Jullien, Jean-Paul Herman
Nucleic Acids Research|October 25, 2003
Regulation of Cre recombinase by ligand-induced complementation of inactive fragmentsNicolas Jullien, François Sampieri, Alain Enjalbert, et al.
Journal of Medicinal Chemistry|November 11, 2009
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitorsNicolas Jullien, Anastasios Makritis, Dimitris Georgiadis, et al.
Medecine Sciences : M/S|April 14, 2009
[Radiotherapy: what therapeutic orientations against the digestive aftereffects?]Agnès François, Fabien Milliat, Nicolas Jullien, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Up-regulation of endothelin type a receptor in human and rat radiation proctitis: preclinical therapeutic approach with endothelin receptor blockadeNicolas Jullien, Karl Blirando, Fabien Milliat, et al.
Journal of Cellular Biochemistry|January 26, 2012
Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cellsNicolas Jullien, Adrien Maudinet, Benjamin Leloutre, et al.
Nature Methods|December 25, 2012
Conditional genome engineering in Toxoplasma gondii uncovers alternative invasion mechanismsNicole Andenmatten, Saskia Egarter, Allison J Jackson, et al.
Molecular Endocrinology (Baltimore, Md.)|May 29, 2012
Research resource: A genome-wide study identifies potential new target genes for POU1F1Jean-Paul Herman, Nicolas Jullien, Séverine Guillen, et al.
Plos One|December 27, 2007
Conditional transgenesis using Dimerizable Cre (DiCre)Nicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Experimental Neurology|May 16, 2002
Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination for use in cell therapy for pain after partial nerve injuryMary J Eaton, Jean-Paul Herman, Nicolas Jullien, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Biotechniques|October 13, 2011
LUEGO: a cost and time saving gel shift procedureNicolas Jullien, Jean-Paul Herman
Nucleic Acids Research|October 25, 2003
Regulation of Cre recombinase by ligand-induced complementation of inactive fragmentsNicolas Jullien, François Sampieri, Alain Enjalbert, et al.
Journal of Medicinal Chemistry|November 11, 2009
Phosphinic tripeptides as dual angiotensin-converting enzyme C-domain and endothelin-converting enzyme-1 inhibitorsNicolas Jullien, Anastasios Makritis, Dimitris Georgiadis, et al.
Medecine Sciences : M/S|April 14, 2009
[Radiotherapy: what therapeutic orientations against the digestive aftereffects?]Agnès François, Fabien Milliat, Nicolas Jullien, et al.
International Journal of Radiation Oncology, Biology, Physics|May 12, 2009
Up-regulation of endothelin type a receptor in human and rat radiation proctitis: preclinical therapeutic approach with endothelin receptor blockadeNicolas Jullien, Karl Blirando, Fabien Milliat, et al.
Journal of Cellular Biochemistry|January 26, 2012
Downregulation of ErbB3 by Wnt3a contributes to wnt-induced osteoblast differentiation in mesenchymal cellsNicolas Jullien, Adrien Maudinet, Benjamin Leloutre, et al.
Nature Methods|December 25, 2012
Conditional genome engineering in Toxoplasma gondii uncovers alternative invasion mechanismsNicole Andenmatten, Saskia Egarter, Allison J Jackson, et al.
Molecular Endocrinology (Baltimore, Md.)|May 29, 2012
Research resource: A genome-wide study identifies potential new target genes for POU1F1Jean-Paul Herman, Nicolas Jullien, Séverine Guillen, et al.
Plos One|December 27, 2007
Conditional transgenesis using Dimerizable Cre (DiCre)Nicolas Jullien, Isabelle Goddard, Samia Selmi-Ruby, et al.
Experimental Neurology|May 16, 2002
Immortalized chromaffin cells disimmortalized with Cre/lox site-directed recombination for use in cell therapy for pain after partial nerve injuryMary J Eaton, Jean-Paul Herman, Nicolas Jullien, et al.
Pageof 4